Golden
Celularity

Celularity

Celuarity is a commercial stage cellular therapeutic company focusing on allogenic cellular therapies.

Celuarity is a commercial stage cellular therapeutic company focusing on allogenic cellular therapies. Celularity is headquartered in Warren, New Jersey and was founded in 2016 by Carlos Ramirez, Jerome Zeldis, Jodi Gurney, John R Haines, Robert Hariri, and Steven French.

Funding

Venture round 1

On September 28, 2017 Celularity announced closing a venture round raising $40 million in capital from undisclosed investors. 

Venture round 2

On February 15, 2018 Celularity completed their second round of venture funding with $250 million in capital from Colgene (lead investor), United Therapeutics, Sorrento Therapeutics, Section 32, Human Longetivity, Celgene, Bill Maris, and Tony Robbins. 



Timeline

February 15, 2018

Venture round 2

On February 15, 2018 Celularity completed their second round of venture funding with $250 million in capital from Colgene (lead investor), United Therapeutics, Sorrento Therapeutics, Section 32, Human Longetivity, Celgene, Bill Maris, and Tony Robbins. 

September 28, 2017

Venture round 1

On September 28, 2017 Celularity announced closing a venture round raising $40 million in capital from undisclosed investors. 

2016

Founding of Celularity

Celularity is headquartered in Warren, New Jersey and was founded in 2016 by Carlos Ramirez, Jerome Zeldis, Jodi Gurney, John R Haines, Robert Hariri, and Steven French.

People

Name
Role
LinkedIn







Further reading

Title
Author
Link
Type
Date

Celularity Announces $250M in Funding to Deliver Treatments for Cancer, Inflammatory and Degenerative Diseases, and Functional Regeneration

Celularity

Web



Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services









References